Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Korea Health Ministry Mulling Expansion Of OTC Drug Sales: Will Korea Follow The Japan Model?

This article was originally published in PharmAsia News

Executive Summary

SEOUL - South Korea's Ministry of Health and Welfare is now working on a healthcare package aimed at allowing sales of some over-the-counter drugs at supermarkets and convenience shops, an effort that would expand OTC sales beyond traditional pharmacy outlets

You may also be interested in...



Korea Allows Sales Of OTC Products In Supermarkets July 21, But Distribution Remains A Challenge

SEOUL - South Koreans are expected to be able to purchase 48 new over-the-counter products at supermarkets and conveniences stores, previously only available at pharmacies, beginning July 21, but consumers found that companies need more time to allow for the expanded distribution and manufacturing

Korea Allows Sales Of OTC Products In Supermarkets July 21, But Distribution Remains A Challenge

SEOUL - South Koreans are expected to be able to purchase 48 new over-the-counter products at supermarkets and conveniences stores, previously only available at pharmacies, beginning July 21, but consumers found that companies need more time to allow for the expanded distribution and manufacturing

South Korea’s Wider OTC Access Excludes Painkillers, Cough/Cold Products

South Korea's Ministry of Health and Welfare will allow 44 OTC drug and nutritional products, excluding painkillers, cough/cold products and other common OTCs, to be sold outside of pharmacies.

Related Content

UsernamePublicRestriction

Register

OM005385

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel